내부 외상 고정 디바이스 시장 규모 : 제품, 재료 유형, 용도, 최종 용도별, 예측(2024-2032년)

Global Internal Trauma Fixation Devices Market will accumulate at a 4.3% CAGR between 2024 and 2032, propelled by the development of biocompatible materials and the growing demand for minimally invasive procedures. Biocompatible materials enhance patient safety and device integration, reducing complications and improving outcomes. As medical advancements focus on less invasive techniques, fixation devices designed for easier implantation and quicker recovery become increasingly desirable. This shift towards advanced materials and minimally invasive solutions meets both patient and provider needs, fostering market growth and driving innovation in trauma fixation technologies.

For instance, in September 2023, Orthofix Medical Inc. launched the Galaxy Fixation Gemini system in the U.S., marking its first patient procedures. This stable external fixation system, available in various sterile kits, offers a quick solution for treating limb fractures. The availability of various sterile kits streamlines the application process, offering a convenient and efficient solution for trauma cases. This innovation could drive market growth by increasing the adoption of advanced fixation technologies, improving patient outcomes, and expanding treatment options in the global market.

The internal trauma fixation devices market is divided based on product, material type, application, end-use, and region.

The nails segment will see a considerable surge by 2032, attributed to their widespread use and effectiveness in treating fractures. Intramedullary nails offer stable fixation for long bone fractures, promoting quicker recovery and improved functional outcomes. Their minimally invasive application and adaptability to various fracture types enhance their preference among orthopedic surgeons. As advancements in nail technology and an increasing incidence of trauma-related injuries drive demand, the nails segment continues to dominate the internal trauma fixation devices industry.

The titanium alloy segment will amass notable gains by 2032, driven by its superior strength, lightweight properties, and biocompatibility. Titanium alloys offer excellent resistance to corrosion and fatigue, making them ideal for use in high-stress environments such as orthopedic implants. Their ability to integrate well with bone tissue and reduce the risk of rejection or complications further enhances their appeal. As the demand for durable and effective fixation solutions grows, titanium alloys' advanced material properties ensure their leading position in the market.

Europe will achieve a moderate CAGR through 2032, owing to advanced healthcare infrastructure and a strong emphasis on orthopedic innovation. The region's high standards for medical technology and significant investments in research and development drive the demand for sophisticated trauma fixation solutions. Besides, the presence of major medical device manufacturers and a growing aging population contribute to market expansion. Europe's commitment to high-quality healthcare and technological advancement positions it as a crucial contributor to the internal trauma fixation devices industry.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing incidence of sports and traumatic injuries
    • 3.2.1.2 Growing demand for orthopedic implants
    • 3.2.1.3 Technological advancements
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of fixation devices
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Reimbursement scenario
• 3.6 Porter's analysis
• 3.7 PESTEL analysis
• 3.8 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Plates
• 5.3 Nails
• 5.4 Screws
• 5.5 Other products

Chapter 6 Market Estimates and Forecast, By Material Type, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Stainless steel
• 6.3 Titanium alloy
• 6.4 Bioabsorbable

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Lower extremity
  • 7.2.1 Foot & ankle
  • 7.2.2 Knee
  • 7.2.3 Lower leg
  • 7.2.4 Hip and pelvic
  • 7.2.5 Spine
  • 7.2.6 Thigh
• 7.3 Upper extremity
  • 7.3.1 Arm
  • 7.3.2 Hand & wrist
  • 7.3.3 Shoulder
  • 7.3.4 Elbow

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Orthopedic clinics
• 8.4 Ambulatory surgical centers

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Acumed LLC
• 10.2 Arthrex, Inc.
• 10.3 B. Braun SE
• 10.4 CONMED Corporation
• 10.5 evonos GmbH & Co. KG
• 10.6 Implanet SA
• 10.7 Integra LifeSciences Holdings Corporation
• 10.8 Johnson & Johnson
• 10.9 KLS Martin Group
• 10.10 Medicon eG
• 10.11 Orthofix US LLC
• 10.12 Smith+Nephew
• 10.13 Stryker Corporation
• 10.14 Wright Medical Group N.V.
• 10.15 Zimmer Biomet